Page 18 - Volume 69 Number 2
P. 18

Whereas, it also drives up the medical costs of administering chemotherapy without adding value, and
Whereas, the failings of the buy-and-bill system impact all oncologists, but small independent practices shoulder the greater burden, and
Whereas, the very existence of small independent practices is threatened, and with it access to care for many of our most vulnerable patients, and
Whereas, “freeing oncologists from dependency on drug revenues while keeping outpatient oncology viable requires a focus on reimbursement for services that are uncompensated or undercompensated in the current system;” therefore be it
RESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to advocate for a change to the Medicare reimbursement formula such that the costs of chemotherapeutic agents are covered, plus an unrelated flat fee to cover the cost of the infusion or injection of said agents; and be it further
RESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to support adequate reimbursement for outpatient oncol- ogy office visits that recognizes the complexity of
the patient’s care management, as these services are often uncompensated or undercompensated in the current system.
WAYS AND MEANS COMMITTEE FISCAL NOTE: NONE
Source(s): https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4594838/
6. RESOLUTION 24-17
Title: Single-Payer Health Insurance Introduced by: Robert Sain, MD, for the Washtenaw
County Delegation Original Author: Robert Sain, MD
Referred to: Reference Committee B House Action:
Whereas, with the anticipated repeal of the Affordable Care Act (ACA) in the national offing, this is a propitious time for MSMS to invigorate support of the adoption of a single-payer financing mechanism for health insurance as MSMS previously considered under Resolution 32-14, and
Whereas, a single payer system has advantages to medical practices including simplicity of billing and administration, and
Whereas, Medicare as a model receives high satisfac- tion ratings from patients and, when adequately funded, is a model for an efficient single payer system with low overhead of approximately three percent, and
Whereas, nearly all advanced countries have a well-functioning single payer system that is embraced by their citizens, and
Whereas, a single payer system can help Michigan businesses to be more competitive by eliminating their involvement in purchasing health care for their employees, and
Whereas, a single payer system provides the opportu- nity to improve medical care per themes identified in the MSMS Future of Medicine report, including “Universal Coverage,” “Prevention and Wellness,” and “Partnering with Patients;” therefore be it
RESOLVED: That MSMS create a Health Care Financ- ing Task Force to review various models for financing health care, including, but not limited to, physician- designed single-payer health insurance, and report to the 2018 MSMS House of Delegates on its deliberations.
WAYS AND MEANS COMMITTEE FISCAL NOTE: This request would require MSMS to engage with a consulting firm with expertise in this area. Estimates range from $50,000 - $60,000.
7. RESOLUTION 65-17
Title: Identification of Non-Financial Conflicts of Interest
Introduced by: James Szocik, MD, for the Washtenaw County Delegation
Original Author: James Szocik, MD Referred to: Reference Committee C House Action:
Whereas, current conflict of interest statements clearly identify financial conflicts of interest, and
Whereas, there are other conflicts of interest that exist that need to be declared and managed, and Whereas, regulatory capture is an example of a
non-financial conflict of interest, and
Whereas, when regulatory capture occurs, the inter-
ests of firms or political groups are prioritized over the interests of the public, leading to a net loss to society as a whole, and
Whereas, these non-financial conflicts such as regula- tory capture can be important and influence the practice of medicine4 and the public health5,3; therefore be it
RESOLVED: That MSMS amend its current conflict of interest policies to explicitly recognize regulatory capture as a conflict of interest in addition to financial and other conflicts of interest. Regulatory capture is defined as “a form of government failure that occurs when a regulatory agency, created to act in the public interest, instead advances the commercial or political concerns of special interest groups that dominate the industry or sector it is charged with regulating.”
WAYS AND MEANS COMMITTEE FISCAL NOTE: NONE
18 Washtenaw County Medical Society BULLETIN
APRIL / MAY / JUNE 2017


































































































   16   17   18   19   20